Tiza–Titre increase and enhanced immunity through an adjuvanted, recombinant herpes zoster subunit vaccine in patients with liver cirrhosis and post-liver transplantation: a study protocol for a prospective cohort study

INTRODUCTION: Shingrix, an effective adjuvanted, recombinant herpes zoster vaccine (RZV), has been available since 2018. Immunocompromised patients are known to be predisposed to vaccine failure. In-vitro testing of immunological surrogates of vaccine protection could be instrumental for monitoring...

Descripción completa

Detalles Bibliográficos
Autores principales: Vollmer-Raschdorf, Stephanie, Rashidi-Alavijeh, Jassin, Voigt, Sebastian, Hengel, Hartmut, Borchardt, Benjamin, Huzly, Daniela, Hüßler, Eva-Maria, in der Schmitten, Jürgen, Halenius, Anne, Willuweit, Katharina, Botzenhardt, Suzan, Trilling, Mirko, Boettler, Tobias, Dehnen, Dorothea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
General practice / Family practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626838/
https://www.ncbi.nlm.nih.gov/pubmed/37918931
http://dx.doi.org/10.1136/bmjopen-2023-074461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626838/
https://www.ncbi.nlm.nih.gov/pubmed/37918931
http://dx.doi.org/10.1136/bmjopen-2023-074461

Ejemplares similares